Quercetin for inhibition of inflammatory responses and oxidative stress in lung injury model: a systematic review and meta-analysis
Acute lung injury (ALI) is a life-threatening clinical syndrome with high morbidity and mortality. The main pathological features of ALI are increased alveolar-capillary membrane permeability, edema, uncontrolled migration of neutrophils to the lungs, and diffuse alveolar damage, resulting in acute...
Gespeichert in:
Veröffentlicht in: | Egyptian Journal of Bronchology 2023-12, Vol.17 (1), p.71-8, Article 71 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Acute lung injury (ALI) is a life-threatening clinical syndrome with high morbidity and mortality. The main pathological features of ALI are increased alveolar-capillary membrane permeability, edema, uncontrolled migration of neutrophils to the lungs, and diffuse alveolar damage, resulting in acute hypoxemic respiratory failure. We performed a systematic review and meta-analysis to elucidate the antioxidant activities of flavanols in a rat model of acute lung injury (ALI). PubMed, EMBASE, Scopus, ProQuest, Web of Science, and Google Scholar databases were searched to obtain the relevant papers. Nine studies with 343 rat models of ALI were included in this study. We investigated oxidative stress with the corresponding 95% CI. Estimating the correlation and 95% CIs for the inflammatory agents and oxidative stress in the intervention group, compared with that in the control group (ALI), respectively (correlation: 0.635; 95% CI, 0.560–0.699,
P
value = 0.000,
Z
value= 12.648) and (correlation: 0.317; 95% CI, 0.189–0.434,
P
value = 0.00,
Z
value= 4.7). In conclusion, investigating the effects of different flavanols on oxidative stress in lung injury may provide a useful therapeutic strategy in ALI mouse models. However, the final conclusion on treatment efficacy should be sufficient for prospective controlled randomized trials. |
---|---|
ISSN: | 2314-8551 1687-8426 2314-8551 |
DOI: | 10.1186/s43168-023-00245-y |